Studying Differences Between the Sexes May Spur Improvements in Medicine

It's hard to believe that only a little over two decades ago, the U.S. government issued guidelines recommending that pharmaceutical companies exclude women of childbearing age from participating in clinical trials. Now the National Institutes of Health has an office devoted to women's health research, and more women are being included in critical medical research. That is progress, to be sure. But it has become increasingly clear that to improve medicine for both men and women, more also needs

Written byMary-lou Pardue
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

That is progress, to be sure. But it has become increasingly clear that to improve medicine for both men and women, more also needs to be done to study differences between the sexes. For too long, the research community has ignored the fact that being male or female encompasses far more than reproductive systems and hormones. Sexually determined characteristics can be found all the way down to the cellular level, and they have important implications that influence how long we live, how we are affected by disease and medication, and even how our brains function.

I recently chaired a panel of the Institute of Medicine that examined the scientific literature on how molecular and biological differences between the sexes affect health. We concluded that it would benefit everyone--men and women alike--if biomedical researchers started paying more attention to these differences. Doing so could identify new ways to promote good health ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies